|
| | Dr. Reitz has had 27 years of experience as a medicinal chemist in the pharmaceutical industry, including nearly 26 years with Johnson & Johnson. He is a co-inventor as well as Team Leader in most cases of seven compounds that have entered human clinical trials, several of which are currently in the clinic (Phase I and II). He has ca. 130 scientific publications and 40 issued U.S. patents, and is the Editor-in-Chief of the journal Current Topics in Medicinal Chemistry. He has extensive experience in probe design and synthesis, target validation, hit triage, hit to lead and lead optimization medicinal chemistry, eADME profiling, and preclinical candidate selection. Dr. Reitz is located at the Pennsylvania Biotechnology Center in Doylestown, PA with research interests in the area of anti-infective agents, protein function and neurology (amyotrophic lateral sclerosis). Dr. Reitz is also Prof. of Chemical Biology in the Institute of Hepatitis and Virus Research.
|
